Bayer CropScience Ltd impressed the Street with strong performance for the March quarter (Q4). The stock gained 11% in Tuesday afternoon trade, hitting new 52-week high.
Revenue jumped 82% from the year ago quarter, helped by favorable base, amalgamation of Monsanto India Ltd, and strong product off-take in the rabi season.
Revenues in the year-ago quarter had more than halved. Amalgamation of Monsanto India with Bayer CropScience came into effect in FY20 and previous fiscal’s (FY19) figures had been restated accordingly. “Bayer CropScience reported better than expected result during 4QFY20," analysts at Antique Stock Broking Ltd said in a note. “It was despite challenges faced on account of covid-19 during March 2020." Profit before